Ost-müük Enochian Biosciences, Inc. - ENOB CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | - | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.025457% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.003235% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Enochian Biosciences Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Eelmine sulgemine* | N/A |
Avatud* | N/A |
Aastane muutus* | N/A |
Päeva ulatus* | N/A |
52 nädala ulatus | 0.72-4.20 |
Keskmine maht (10 päeva) | 50.44K |
Keskmine maht (3 kuud) | 1.23M |
Turukapitalisatsioon | 52.37M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 58.28M |
Tulu | N/A |
EPS | -2.00 |
Dividendid (% kasumist) | N/A |
Beeta | 1.10 |
Järgmine tuluaruande kuupäev | N/A |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|
Enochian Biosciences, Inc. Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
Thursday, June 22, 2023 | ||
Kellaaeg (UTC) (UTC) 16:00 | Riik US
| Sündmus Enochian Biosciences Inc Annual Shareholders Meeting Enochian Biosciences Inc Annual Shareholders MeetingForecast -Previous - |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 0 | 0 | 0 | 0 | 0 |
Tulu | 0 | 0 | 0 | 0 | |
Kulud, Kokku | 0 | 0 | 0 | ||
Brutokasum | 0 | 0 | 0 | ||
Kogu tegevuskulu | 116.079 | 23.4018 | 11.7838 | 10.99 | 5.24151 |
Müük/Üldine/admin kulud, kokku | 14.3298 | 7.74013 | 7.12084 | 8.42022 | 4.69388 |
Uuringud ja arendus | 8.3728 | 15.5381 | 4.69435 | 2.49811 | 0.61696 |
Depreciation / Amortization | 0.12359 | 0.12354 | 0.10858 | 0.07171 | 0.01848 |
Tulud majandustegevusest | -116.079 | -23.4018 | -11.7838 | -10.99 | -5.24151 |
Intressitulud (kulu), muud tulud, neto | -0.25079 | -0.39906 | 0.09285 | 0.04714 | 0.19297 |
Netotulu enne makse | -113.433 | -26.8489 | -11.4164 | -18.0165 | -6.42355 |
Netotulu pärast makse | -113.433 | -26.7236 | -11.4164 | -18.0165 | -6.31184 |
Netotulu enne erikulusid | -113.433 | -26.7236 | -11.4164 | -18.0165 | -6.31184 |
Netotulu | -113.433 | -26.7236 | -11.4164 | -18.0165 | -6.31184 |
Arvestatav tulu, v a erikulud | -113.433 | -26.7236 | -11.4164 | -18.0165 | -6.31184 |
Arvestatav tulu, koos erikuludega | -113.433 | -26.7236 | -11.4164 | -18.0165 | -6.31184 |
Jaotamisele kuuluv netotulu | -113.433 | -26.7236 | -11.4164 | -18.0165 | -6.31184 |
Keskmine jaotamisele kuuluv aktsia kohta | 52.528 | 47.1673 | 46.3307 | 37.5521 | 21.9405 |
Jaotatav EPS, v a erakorralised kulud | -2.15948 | -0.56657 | -0.24641 | -0.47977 | -0.28768 |
Jaotamisele kuuluv normaal-EPS | -1.00554 | -0.56657 | -0.24943 | -0.47977 | -0.29028 |
Ootamatud kulutused (tulu) | 93.253 | 0 | -0.14 | 0 | -0.08782 |
Dividends per Share - Common Stock Primary Issue | |||||
Muud, neto | 2.89663 | -3.04803 | 0.27457 | -7.07358 | -1.375 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kogutulu | 0 | 0 | 0 | 0 | 0 |
Tulu | 0 | 0 | 0 | ||
Kulud, Kokku | |||||
Brutokasum | |||||
Kogu tegevuskulu | 4.06344 | 4.36787 | 7.6098 | 98.2092 | 4.03456 |
Müük/Üldine/admin kulud, kokku | 3.79606 | 4.01306 | 4.55684 | 3.16008 | 2.79046 |
Uuringud ja arendus | 0.23914 | 0.32596 | 2.60538 | 1.76776 | 1.21238 |
Depreciation / Amortization | 0.02824 | 0.02885 | 0.0284 | 0.02833 | 0.03172 |
Tulud majandustegevusest | -4.06344 | -4.36787 | -7.6098 | -98.2092 | -4.03456 |
Intressitulud (kulu), muud tulud, neto | -0.26486 | -0.08988 | -0.08997 | 0.00463 | -0.08792 |
Muud, neto | 0 | 0 | 7.96752 | -2.07899 | |
Netotulu enne makse | -4.3283 | -4.45775 | -7.69976 | -90.237 | -6.20147 |
Netotulu pärast makse | -4.3283 | -4.45775 | -7.69976 | -90.237 | -6.20147 |
Netotulu enne erikulusid | -4.3283 | -4.45775 | -7.69976 | -90.237 | -6.20147 |
Netotulu | -4.3283 | -4.45775 | -7.69976 | -90.237 | -6.20147 |
Arvestatav tulu, v a erikulud | -4.3283 | -4.45775 | -7.69976 | -90.237 | -6.20147 |
Arvestatav tulu, koos erikuludega | -4.3283 | -4.45775 | -7.69976 | -90.237 | -6.20147 |
Jaotamisele kuuluv netotulu | -4.3283 | -4.45775 | -7.69976 | -90.237 | -6.20147 |
Keskmine jaotamisele kuuluv aktsia kohta | 55.9746 | 55.5092 | 55.0995 | 52.937 | 52.6388 |
Jaotatav EPS, v a erakorralised kulud | -0.07733 | -0.08031 | -0.13974 | -1.70461 | -0.11781 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Jaotamisele kuuluv normaal-EPS | -0.07733 | -0.08031 | -0.13214 | 0.05697 | -0.11781 |
Ootamatud kulutused (tulu) | 0 | 0.41918 | 93.253 | ||
Other Operating Expenses, Total | 0 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Käibevarad kokku | 9.56514 | 20.899 | 8.94121 | 12.495 | 15.762 |
Raha ja lühiajalised investeeringud | 9.17214 | 20.6644 | 8.69636 | 12.2822 | 15.6009 |
Cash | 9.17214 | 20.6644 | 8.69636 | 12.2822 | 15.6009 |
Laekumata arved, neto | 0.00164 | 0.00198 | 0.02079 | 0.12287 | |
Prepaid Expenses | 0.393 | 0.23294 | 0.24287 | 0.19197 | 0.03828 |
Other Current Assets, Total | |||||
Total Assets | 84.6327 | 189.605 | 178.102 | 179.877 | 182.502 |
Property/Plant/Equipment, Total - Net | 1.74362 | 2.15534 | 2.48198 | 0.68752 | 0.0274 |
Intangibles, Net | 61.6153 | 154.89 | 154.901 | 154.917 | 154.935 |
Other Long Term Assets, Total | 0.06864 | 0.02098 | 0.13755 | 0.13755 | 0.13755 |
Total Current Liabilities | 6.45097 | 1.88589 | 1.3348 | 1.11042 | 0.87372 |
Accounts Payable | 1.40187 | 0.32056 | 0.59288 | 0.77356 | 0.80681 |
Accrued Expenses | 1.2851 | 1.47473 | 0.74192 | 0.33685 | 0.06691 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 1.2 | ||||
Total Liabilities | 12.0138 | 14.9423 | 11.8298 | 6.77742 | 23.7647 |
Total Long Term Debt | 4.57715 | 5.77911 | 5.78079 | 0 | 0 |
Total Equity | 72.6189 | 174.663 | 166.272 | 173.1 | 158.738 |
Common Stock | 0.0053 | 0.00522 | 0.00465 | 0.00453 | 0.00362 |
Additional Paid-In Capital | 276.989 | 265.58 | 230.497 | 225.765 | 193.284 |
Retained Earnings (Accumulated Deficit) | -204.345 | -90.9118 | -64.1882 | -52.7718 | -34.7554 |
Other Equity, Total | -0.03044 | -0.01083 | -0.04142 | 0.10182 | 0.20568 |
Total Liabilities & Shareholders’ Equity | 84.6327 | 189.605 | 178.102 | 179.877 | 182.502 |
Total Common Shares Outstanding | 53.0071 | 52.2197 | 46.4974 | 45.2739 | 36.1639 |
Note Receivable - Long Term | |||||
Property/Plant/Equipment, Total - Gross | 2.1011 | 2.416 | 2.63499 | 0.74667 | 0.26117 |
Accumulated Depreciation, Total | -0.35748 | -0.26066 | -0.15301 | -0.05915 | -0.23377 |
Goodwill, Net | 11.64 | 11.64 | 11.64 | 11.64 | 11.64 |
Other Liabilities, Total | 0.9857 | 7.27728 | 4.71421 | 5.667 | 22.891 |
Long Term Debt | 4.57715 | 5.77911 | 5.78079 | ||
Other Current Liabilities, Total | 2.564 | 0.0906 | |||
Preferred Stock - Non Redeemable, Net | 0 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Käibevarad kokku | 3.92693 | 5.38947 | 8.13255 | 9.56514 | 11.6957 |
Raha ja lühiajalised investeeringud | 2.94804 | 4.1189 | 7.97192 | 9.17214 | 11.1509 |
Cash | 2.94804 | 4.1189 | 7.97192 | 9.17214 | 11.1509 |
Laekumata arved, neto | 0 | ||||
Prepaid Expenses | 0.97888 | 1.27058 | 0.16063 | 0.393 | 0.54474 |
Total Assets | 78.7307 | 80.2737 | 83.0706 | 84.6327 | 180.101 |
Property/Plant/Equipment, Total - Net | 1.49312 | 1.56917 | 1.62177 | 1.74362 | 1.86862 |
Property/Plant/Equipment, Total - Gross | 1.93152 | 1.9809 | 2.00616 | 2.1011 | 2.21307 |
Accumulated Depreciation, Total | -0.43839 | -0.41173 | -0.38439 | -0.35748 | -0.34445 |
Goodwill, Net | 11.64 | 11.64 | 11.64 | 11.64 | 11.64 |
Intangibles, Net | 61.6121 | 61.6131 | 61.611 | 61.6153 | 154.875 |
Other Long Term Assets, Total | 0.05859 | 0.06194 | 0.06529 | 0.06864 | 0.02174 |
Total Current Liabilities | 11.7734 | 11.292 | 7.15908 | 6.45097 | 7.51165 |
Accounts Payable | 4.47135 | 4.55523 | 4.68275 | 1.40187 | 0.48702 |
Accrued Expenses | 0.79995 | 1.13497 | 1.2408 | 1.2851 | 0.74499 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.50105 | 0.87542 | 0.03554 | 2.564 | 0.27771 |
Total Liabilities | 12.6026 | 13.3743 | 12.7457 | 12.0138 | 18.8579 |
Total Long Term Debt | 0 | 1.2 | 4.65177 | 4.57715 | 0 |
Long Term Debt | 0 | 1.2 | 4.65177 | 4.57715 | 0 |
Other Liabilities, Total | 0.82921 | 0.8823 | 0.93486 | 0.9857 | 11.3463 |
Total Equity | 66.1282 | 66.8994 | 70.3248 | 72.6189 | 161.243 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.0058 | 0.00557 | 0.00555 | 0.0053 | 0.00528 |
Additional Paid-In Capital | 286.986 | 283.427 | 282.402 | 276.989 | 275.367 |
Retained Earnings (Accumulated Deficit) | -220.831 | -216.503 | -212.045 | -204.345 | -114.108 |
Other Equity, Total | -0.03239 | -0.03028 | -0.03819 | -0.03044 | -0.02149 |
Total Liabilities & Shareholders’ Equity | 78.7307 | 80.2737 | 83.0706 | 84.6327 | 180.101 |
Total Common Shares Outstanding | 57.9836 | 55.7055 | 55.5071 | 53.0071 | 52.7983 |
Current Port. of LT Debt/Capital Leases | 6.00101 | 4.72639 | 1.2 | 1.2 | 6.00194 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -113.433 | -26.7236 | -11.4164 | -18.0165 | -6.31184 |
Raha majandustegevusest | -15.7323 | -20.6107 | -10.4594 | -8.50734 | -4.33827 |
Amortization | |||||
Mittelikviidsed varad | 96.1624 | 5.05722 | 0.94582 | 9.23855 | 2.02766 |
Muutused tööjõus | 1.41511 | 0.93213 | -0.09747 | 0.19889 | -0.07258 |
Tulu investeeringutelt | -0.00516 | -0.04889 | -0.18446 | -0.71667 | -0.57573 |
Muud rahavood investeeringutelt, kokku | 0 | -0.54573 | |||
Rahavood investeeringutelt | 4.25046 | 32.6016 | 7.2 | 6.02 | 16.7127 |
Rahavoogudesse investeerimine | 4.6764 | 28.0653 | |||
Aktsiate emiteerimine (tagasiost), neto | 0.13491 | 5.08286 | 1 | 6.02 | 16.7127 |
Laenu väljastamine (kustutamine), neto | -0.56085 | -0.54665 | 6.2 | ||
Muutused valuutakursside kõikumisest | -0.00524 | 0.02611 | -0.14198 | -0.11463 | -0.13956 |
Rahaline kogumuutus | -11.4923 | 11.9681 | -3.58586 | -3.31864 | 11.6592 |
Cash Taxes Paid | 0.00003 | 0.00004 | 0 | 0 | 0 |
Makstud intressid | 0.07972 | 0.08922 | 0 | 0.00004 | 0.14324 |
Raha majandustegevusest | 0.12359 | 0.12353 | 0.10858 | 0.07171 | 0.01848 |
Kapitalikulutused | -0.00516 | -0.04889 | -0.18446 | -0.71667 | -0.03 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -16.4858 | -12.1575 | -7.69976 | -113.433 | -23.1964 |
Cash From Operating Activities | -9.51294 | -6.20515 | -2.8203 | -15.7323 | -12.6819 |
Cash From Operating Activities | 0.08549 | 0.05725 | 0.0284 | 0.12359 | 0.09526 |
Non-Cash Items | 3.56521 | 2.41439 | 1.51981 | 96.1624 | 10.8507 |
Cash Taxes Paid | 0 | 0 | 0 | 0.00003 | 0.00003 |
Cash Interest Paid | 0.04363 | 0.03033 | 0.03033 | 0.07972 | 0.05588 |
Changes in Working Capital | 3.32217 | 3.48073 | 3.33125 | 1.41511 | -0.43148 |
Cash From Investing Activities | -0.02363 | -0.02363 | 0 | -0.00516 | -0.00516 |
Capital Expenditures | -0.02363 | -0.02363 | 0 | -0.00516 | -0.00516 |
Cash From Financing Activities | 3.26701 | 1.15838 | 1.625 | 4.25046 | 3.18027 |
Issuance (Retirement) of Stock, Net | 4.108 | 1.625 | 1.625 | 0.13491 | 0.13 |
Issuance (Retirement) of Debt, Net | -0.84099 | -0.46663 | -0.56085 | -0.44977 | |
Foreign Exchange Effects | 0.04546 | 0.01716 | -0.00493 | -0.00524 | -0.00676 |
Net Change in Cash | -6.2241 | -5.05325 | -1.20022 | -11.4923 | -9.51349 |
Financing Cash Flow Items | 0 | 4.6764 | 3.50004 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
Gumrukcu (Serhat) | Individual Investor | 21.4924 | 12526552 | 0 | 2023-05-10 | LOW |
RS Group ApS | Corporation | 18.846 | 10984141 | 1315790 | 2023-05-10 | LOW |
William (Anderson Wittekind) | Individual Investor | 8.8437 | 5154446 | 38121 | 2023-05-10 | LOW |
Sandler (Carl Forest JR) | Individual Investor | 7.5412 | 4395260 | 938429 | 2022-04-15 | |
Weird Science LLC | Corporation | 2.2536 | 1313499 | 0 | 2023-05-10 | |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.8864 | 1099442 | 154743 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 0.5529 | 322276 | -436427 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5471 | 318855 | 72 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.5274 | 307408 | 1800 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.2573 | 149960 | 481 | 2023-03-31 | LOW |
Nuveen LLC | Pension Fund | 0.2085 | 121513 | -3064 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.1931 | 112552 | -55215 | 2023-03-31 | HIGH |
Invesco Advisers, Inc. | Investment Advisor | 0.173 | 100831 | -450 | 2023-03-31 | LOW |
Sapirstein (James E) | Individual Investor | 0.1474 | 85895 | 0 | 2023-05-10 | |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.1166 | 67939 | 0 | 2023-03-31 | LOW |
Dybul (Mark R) | Individual Investor | 0.1141 | 66481 | 0 | 2023-05-10 | LOW |
BlackRock Investment Management, LLC | Investment Advisor/Hedge Fund | 0.1108 | 64603 | 0 | 2023-03-31 | LOW |
Brosgart (Carol L.) | Individual Investor | 0.0867 | 50507 | 0 | 2023-05-10 | LOW |
Alton (Gregg H) | Individual Investor | 0.0867 | 50507 | 0 | 2023-05-10 | LOW |
Gronfeldt-Sorensen (Henrik) | Individual Investor | 0.0858 | 50000 | 0 | 2023-05-10 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group535K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$113M+
Igakuine investeerimise maht
$64M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Enochian Biosciences, Inc. Company profile
Ettevõttest Enochian Biosciences, Inc.
Enochian BioSciences Inc. on prekliinilises staadiumis biotehnoloogia ettevõte. Ettevõte kasutab oma raku-, geeni- ja immuunteraapia tehnoloogiaid inimese immuunpuudulikkuse viiruse (HIV), B-hepatiidi viiruse (HBV), gripi ja koronaviiruse infektsioonide raviks, samuti mõnede kõige surmavamate vähivormide raviks. Ettevõtte tootekandidaatide hulka kuuluvad ENOB-HV-01, autoloogiline siirdamine geneetiliselt muundatud rakkudega; ENOB-HV-11 ja ENOB-HV-12, ennetavad ja terapeutilised vaktsiinid; ENOB-HV-21, immunoteraapia allogeensete NK/GDT rakkudega; ENOB-HV-31, in Vivo geeniteraapia; ENOB-HB-01, potentsiaalne ravi HBV vastu; ENOB-CV-01, aerosool-/ sissehingatav ravi potentsiaalselt kõigi inimeste haigusi põhjustavate koronaviiruste puhul; ENOB-CV-11, aerosool-/ sissehingatav profülaktika potentsiaalselt kõigi inimeste haigusi põhjustavate koronaviiruste puhul; ENOB-FL-01, aerosool-/ sissehingatav ravi potentsiaalselt kõigi gripiviiruste puhul; ja ENOB-FL-11, aerosool-/ sissehingatav profülaktika potentsiaalselt kõigi gripiviiruste puhul.
Industry: | Bio Therapeutic Drugs |
Century City Medical Plaza
2080 Century City East
LOS ANGELES
CALIFORNIA 90067
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com